• Dinaciclib Exploits VHL Deficiency in Clear Cell Renal Carci

  2026-05-07

  This study demonstrates that Dinaciclib, a cyclin-dependent kinase inhibitor, selectively induces cytotoxicity in VHL-deficient clear cell renal cell carcinoma (CC-RCC) cells through synthetic lethality. The research provides a mechanistic rationale for targeting vulnerabilities in CC-RCC and suggests avenues for developing precision therapies.

• Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry:

  2026-05-07

  Wang et al. (2018) systematically dissected the entry mechanism of genotype III grass carp reovirus (GCRV104), revealing that clathrin-mediated, dynamin- and pH-dependent endocytosis governs cellular uptake in kidney cells. These findings clarify the cellular pathways exploited by GCRV104, informing both antiviral strategy development and basic endocytosis research.

• Berberine Hydrochloride: Mechanistic Insights and Research P

  2026-05-06

  Berberine hydrochloride, a natural isoquinoline alkaloid, demonstrates reproducible efficacy in antibacterial, metabolic, and bone loss research. Its AMPK activation and gut-bone axis modulation are supported by recent mechanistic and clinical studies. This article details evidence, limits, and workflow parameters to optimize translational research using APExBIO's Berberine hydrochloride.

• WNT5a/GSK3/β-catenin Axis Controls Muscle FAP Adipogenesis

  2026-05-06

  This study identifies the WNT5a/GSK3/β-catenin signaling pathway as a pivotal regulator of adipogenic differentiation in muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological, single-cell, and transcriptomic approaches, the research demonstrates that modulating this axis can limit pathological fat infiltration in skeletal muscle, providing a mechanistic basis for interventions in myopathies.

• 5-hme-dCTP: Precision Tool for Plant Epigenetic DNA Modifica

  2026-05-05

  5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate) is a modified nucleotide enabling controlled DNA hydroxymethylation for epigenetic research. Its use clarifies 5-hmC’s roles in plant gene expression and drought response, with robust validation for molecular biology workflows.

• ER-Fusogenic Immunogenic Liposomes Boost Cellular Immunity i

  2026-05-05

  This study introduces phosphatidylinositol-based immunogenic nanoliposomes (PI-INLs) that act dually as endogenous adjuvants and ER-targeting antigen carriers, greatly enhancing CD8 T cell responses in anti-tumor vaccine models. The work sets a new paradigm for designing self-adjuvanting nanovaccines using natural phospholipids to achieve potent, coordinated cellular immunity.

• AZ505 SMYD2 Inhibitor: Precision Tools for Epigenetic Oncolo

  2026-05-04

  Explore how AZ505, a potent and selective SMYD2 inhibitor, is redefining cancer and fibrosis research. This article unpacks unique mechanistic insights and practical assay strategies for advanced epigenetic regulation research.

• Strategic Inhibition of TGF-β/Smad in Fibrosis: A 83-01’s Tr

  2026-05-04

  This thought-leadership article explores the mechanistic and translational rationale for targeting TGF-β/Smad signaling in kidney fibrosis, spotlighting the ALK-5 inhibitor A 83-01. We synthesize recent single-cell insights on Spp1-mediated fibroblast activation, benchmark A 83-01’s selectivity and workflow compatibility, and deliver actionable guidance for translational researchers seeking high-fidelity, reproducible models of fibrosis and EMT.

• Engineering IR-1061-Loaded Polystyrene Nanoparticles for Dee

  2026-05-03

  This study demonstrates how optimizing polystyrene nanoparticle polarity and IR-1061 loading conditions yields highly emissive, stable, and biocompatible near-infrared fluorescent probes for deep in vivo imaging. The findings provide a technical advance in overcoming dye aggregation and instability, supporting more robust OTN-NIR molecular imaging applications.

• Toremifene in Breast Cancer: 20 Years of Clinical Evidence

  2026-05-02

  This review synthesizes two decades of clinical data on toremifene, a selective estrogen receptor modulator (SERM), in hormone-sensitive breast cancer. The paper highlights the evolution of endocrine therapy, the impact of pharmacogenomics, and the importance of biomarker-driven personalization, offering insights for future translational research.

• GSK J4 HCl: Advanced Insights into JMJD3 Inhibition and Immu

  2026-05-01

  Explore the multifaceted roles of GSK J4 HCl as a JMJD3 inhibitor in epigenetic regulation research. This article uniquely connects chromatin modulation to immune environment control, offering evidence-based guidance for experimental design.

• Epigenetic Induction of Spermatogonia-like Cells via Chemica

  2026-05-01

  This study presents a chemically defined protocol that elevates expression of LIM homeobox 1 (Lhx1)—a key undifferentiated spermatogonial stem cell marker—in mouse embryonic stem cells differentiated into spermatogonia-like cells. By integrating a DNA methyltransferase inhibitor (RG108) with other small-molecule modulators, the work advances in vitro recapitulation of early male germline development and provides a foundation for dissecting epigenetic mechanisms in germ cell lineage specification.

• Universal HPLC Method for Encapsulation Efficiency in Dual-L

  2026-04-30

  This study introduces and validates a nanoparticle exclusion HPLC method for accurately determining the encapsulation efficiency of dual-loaded liposomes containing drugs with distinct physicochemical properties. The findings provide a robust and broadly applicable workflow for optimizing nanocarrier design in advanced drug delivery, especially for combination cancer therapies.

• I-BET151 (GSK1210151A): Practical Guide for BET Inhibition A

  2026-04-30

  I-BET151 (GSK1210151A) is a selective BET bromodomain inhibitor designed to modulate transcriptional programs in cancer biology. This compound is suitable for apoptosis and cell cycle arrest assays, particularly in models such as MLL-fusion leukemia and glioblastoma, but is not intended for diagnostic or clinical applications.

• Amiloride (MK-870): Mechanistic Insights for Next-Gen Ion Ch

  2026-04-29

  Explore how Amiloride (MK-870) advances sodium channel research by revealing precise mechanisms of epithelial ion transport and cellular signaling. This article delivers a deeper mechanistic and translational perspective distinct from traditional workflow guides.

11462 records 1/765 page Next 12345 下5页 Last page